An emotional farewell to Uttara Kannada DC Krishnaih

Udupi, Jan 30: Fishermen in Udupi’s Malpe have netted ‘spanner crab’, a rare variety of deep sea crab, mostly found in Australia and Hawaiian coast.

Hundreds of onlookers were surprised to the see the catch when it was brought to Malpe harbour by the fisherman Prashanth Kunder and others on Tuesday evening.

Dr Shivakumar Haragi, Assistant Professor at Karnatak University, PG Centre Department of Marine Biology, Karwar identified this crab variety as ‘spanner crab’ and the scientific name of this crab is Ranina Ranina.

Ranina Ranina is mainly nocturnal as it remains active during night and is found buried in sand during the day .It is easily distinguished from other crab species in its habitat due to its red carapace and elongated midsection.

Resembling a frog in its shape, this crab species is found mainly in Africa, Hawaiian coast and also in the Great Barrier Reef, located in the Coral Sea, off the coast of Queensland, Australia. Its lifetime is seven to nine years and each crab weighs around 400-900 grams.

Prashanth Kunder and his associates have also netted a rare fish variety called yellow-edged lyretail. Another unique variety fish netted by Prashanth is epinephelus flavocaeruleus.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.